Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

Ophthalmology

Volumn 112, Issue 4, 2005, Pages 593-598

  Jonas, Jost B ^a,b   Degenring, Robert F ^a   Kreissig, Ingrid ^a   Akkoyun, Imren ^a   Kamppeter, Bernd A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; PROSTAGLANDIN DERIVATIVE; TRIAMCINOLONE ACETONIDE; ANTIHYPERTENSIVE AGENT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FILTERING OPERATION; FOLLOW UP; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFRACTION ERROR; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; SIDE EFFECT; UVEITIS; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG EFFECT; INJECTION; INTRAOCULAR PRESSURE; META ANALYSIS; PROSPECTIVE STUDY; RETINA DISEASE; RISK FACTOR; TIME; VITREOUS BODY;

AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MALE; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; RETINAL DISEASES; RISK FACTORS; TIME FACTORS; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 16244365170     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.10.042     Document Type: Article

References (47)

1. R. Machemer, G. Sugita, Y. Tano Treatment of intraocular proliferations with intravitreal steroids Trans Am Ophthalmol Soc 77 1979 171 180
2. R. Machemer Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was injected into the eye [letter] Retina 16 1996 166 167
3. P. Penfold, J. Gyory, A. Hunyor, F.A. Billson Exudative macular degeneration and intravitreal triamcinolone A pilot study Aust N Z J Ophthalmol 23 1995 293 298
4. J.K. Challa, M.C. Gillies, P.L. Penfold Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up Aust N Z J Ophthalmol 26 1998 277 281
5. R.J. Wingate, P.E. Beaumont Intravitreal triamcinolone and elevated intraocular pressure Aust N Z J Ophthalmol 27 1999 431 432
6. R.P. Danis, T.A. Ciulla, L.M. Pratt, W. Anliker Intravitreal triamcinolone acetonide in exudative age-related macular degeneration Retina 20 2000 244 250
7. J.B. Jonas, I. Kreissig, R.F. Degenring Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration [letter] Graefes Arch Clin Exp Ophthalmol 240 2002 873 874
8. J.B. Jonas, I. Kreissig, P. Hugger Intravitreal triamcinolone acetonide for exudative age-related macular degeneration Br J Ophthalmol 87 2003 462 468
9. M.C. Gillies, J.M. Simpson, W. Luo A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results Arch Ophthalmol 121 2003 667 673
10. R.F. Spaide, J. Sorenson, L. Maranan Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization Ophthalmology 110 2003 1517 1525
11. J.B. Jonas, J.K. Hayler, A. Söfker, S. Panda-Jonas Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone J Glaucoma 10 2001 284 287
12. J.B. Jonas, J.K. Hayler, A. Söfker, S. Panda-Jonas Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy Am J Ophthalmol 131 2001 468 471
13. J.B. Jonas, A. Söfker Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema Am J Ophthalmol 132 2001 425 427
14. A. Martidis, J.S. Duker, P.B. Greenberg Intravitreal triamcinolone for refractory diabetic macular edema Ophthalmology 109 2002 920 927
15. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-24, discussion 224-5.
16. J.B. Jonas, J.K. Hayler, S. Panda-Jonas Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony [letter] Graefes Arch Clin Exp Ophthalmol 239 2001 464 465
17. R.J. Antcliff, D.J. Spalton, M.R. Stanford Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study Ophthalmology 108 2001 765 772
18. S. Young, G. Larkin, M. Branley, S. Lightman Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis Clin Experiment Ophthalmol 29 2001 2 6
19. A. Martidis, J.S. Duker, C.A. Puliafito Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy Arch Ophthalmol 119 2001 1380 1383
20. R.F. Degenring, J.B. Jonas Intravitreal injection of triamcinolone acetonide as treatment of chronic uveitis [letter] Br J Ophthalmol 87 2003 361
21. P.B. Greenberg, A. Martidis, A.H. Rogers Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion [letter] Br J Ophthalmol 86 2002 247 248
22. J.B. Jonas, I. Kreissig, R.F. Degenring Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion Graefes Arch Clin Exp Ophthalmol 240 2002 782 783
23. R.F. Degenring, B. Kamppeter, I. Kreissig, J.B. Jonas Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion Acta Ophthalmol Scand 81 2003 399 401
24. N. Benhamou, P. Massin, B. Haouchine Intravitreal triamcinolone for refractory pseudophakic macular edema Am J Ophthalmol 135 2003 246 249
25. M.D. Conway, C. Canakis, C. Livir-Rallatos, G.A. Peyman Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema J Cataract Refract Surg 29 2003 27 33
26. J.B. Jonas, I. Kreissig, R.F. Degenring Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema Am J Ophthalmol 136 2003 384 386
27. J.B. Jonas, A. Söfker Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularisation J Cataract Refract Surg 28 2002 2040 2041
28. G.A. Peyman, R. Cheema, M.D. Conway, T. Fang Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy Retina 20 2000 554 555
29. J.B. Jonas Intravitreal triamcinolone for treatment of chronic focal immunologic corneal graft reaction [letter] Graefes Arch Clin Exp Ophthalmol 241 2003 779 780
30. E. Bui Quoc, B. Bodaghi, R. Adam Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis [in French] J Fr Ophtalmol 25 2002 1048 1056
31. J.B. Jonas, I. Kreissig, R. Degenring Intraocular pressure after intravitreal injection of triamcinolone acetonide Br J Ophthalmol 87 2003 24 27
32. J.B. Jonas, I. Kreissig, R.F. Degenring Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide Arch Ophthalmol 121 2003 729 730
33. S.J. Bakri, P.M. Beer The effect of intravitreal triamcinolone acetonide on intraocular pressure Ophthalmic Surg Lasers Imaging 34 2003 386 390
34. J.B. Jonas, R.F. Degenring, B.A. Kamppeter Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide J Glaucoma 13 2004 261
35. J.B. Jonas, I. Kreissig, R.F. Degenring Endophthalmitis after intravitreal injection of triamcinolone acetonide [letter] Arch Ophthalmol 121 2003 1663 1664
36. Spandau UHM, Derse M, Schmitz-Valckenberg P, et al. Measurement of triamcinolone acetonide concentration after filtering of solvent agent. Am J Ophthalmol. In press.
37. SPSS for Windows [computer program]. Version 11.5. Chicago: SPSS Inc.; 2003.
38. G.N. Scholes, W.J. O'Brien, G.W. Abrams, M.F. Kubicek Clearance of triamcinolone from vitreous Arch Ophthalmol 103 1985 1567 1569
39. J.B. Jonas Concentration of intravitreally injected triamcinolone acetonide in aqueous humour Br J Ophthalmol 86 2002 1066
40. J.B. Jonas Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil Br J Ophthalmol 86 2002 1450 1451
41. P.M. Beer, S.J. Bakri, R.J. Singh Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection Ophthalmology 110 2003 681 686
42. J.B. Jonas Intraocular availability of triamcinolone acetonide after intravitreal injection Am J Ophthalmol 137 2004 560 562
43. M.S. Benz, T.G. Murray, S.R. Dubovy Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone Arch Ophthalmol 121 2003 271 273
44. P. Palmberg Risk factors for glaucoma progression: where does intraocular pressure fit in? Arch Ophthalmol 119 2001 897 898
45. R. Degenring, J.B. Jonas Serum levels of triamcinolone acetonide after intravitreal injection Am J Ophthalmol 137 2004 1142 1143
46. B. Becker, G. Bresnick, L. Chevrette Intraocular pressure and its response to topical corticosteroids in diabetes Arch Ophthalmol 76 1966 477 483
47. M.C. Gillies, J.M. Simpson, F.A. Billson Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial Arch Ophthalmol 122 2004 336 340